

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01717576 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.01717576 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.00698165 |
| 4 | vocalization behavior (GO:0071625) | 4.98079748 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.95364476 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85361235 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.78288888 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.74502687 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.67423627 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.58286529 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.55462927 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 4.40907041 |
| 13 | protein localization to synapse (GO:0035418) | 4.40059630 |
| 14 | activated T cell proliferation (GO:0050798) | 4.39202525 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.38215535 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.32196691 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.32196691 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.32196691 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.32196691 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.32196691 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.32196691 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.23935316 |
| 23 | locomotory exploration behavior (GO:0035641) | 4.19276402 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19108840 |
| 25 | microglial cell activation (GO:0001774) | 4.13123869 |
| 26 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.11444587 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 4.10670832 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.03982319 |
| 29 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.03981304 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 4.01448228 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.97882756 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.97597807 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.95217471 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.94043072 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.91396382 |
| 36 | neuronal action potential propagation (GO:0019227) | 3.86030704 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84977145 |
| 38 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.83254152 |
| 39 | neuron recognition (GO:0008038) | 3.81477580 |
| 40 | response to histamine (GO:0034776) | 3.80545261 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.80154030 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.76000972 |
| 43 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.75127841 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66711663 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66353074 |
| 46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.65962816 |
| 47 | cellular extravasation (GO:0045123) | 3.64318229 |
| 48 | axonal fasciculation (GO:0007413) | 3.64118104 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.61596285 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.61191463 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.60591663 |
| 52 | detection of other organism (GO:0098543) | 3.59715548 |
| 53 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.59556526 |
| 54 | neutrophil activation (GO:0042119) | 3.58627167 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.57242011 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56447671 |
| 57 | glutamate secretion (GO:0014047) | 3.55956808 |
| 58 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.55170191 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.55167667 |
| 60 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52661502 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.51280915 |
| 62 | long-term memory (GO:0007616) | 3.48545587 |
| 63 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48470829 |
| 64 | response to peptidoglycan (GO:0032494) | 3.45734166 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 3.43926454 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.43717342 |
| 67 | leukocyte aggregation (GO:0070486) | 3.43130567 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.42747403 |
| 69 | postsynaptic membrane organization (GO:0001941) | 3.42091888 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.40973996 |
| 71 | auditory behavior (GO:0031223) | 3.40760362 |
| 72 | regulation of synaptic vesicle transport (GO:1902803) | 3.39213609 |
| 73 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.38506579 |
| 74 | long-term synaptic potentiation (GO:0060291) | 3.38398724 |
| 75 | detection of bacterium (GO:0016045) | 3.37669970 |
| 76 | synaptic vesicle maturation (GO:0016188) | 3.36102970 |
| 77 | regulation of synapse structural plasticity (GO:0051823) | 3.33461566 |
| 78 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.33285194 |
| 79 | negative regulation of interleukin-1 production (GO:0032692) | 3.32887894 |
| 80 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.32714756 |
| 81 | membrane hyperpolarization (GO:0060081) | 3.32285625 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 3.31381556 |
| 83 | positive regulation of membrane potential (GO:0045838) | 3.28910811 |
| 84 | positive regulation of neurotransmitter transport (GO:0051590) | 3.27911990 |
| 85 | response to auditory stimulus (GO:0010996) | 3.26142032 |
| 86 | startle response (GO:0001964) | 3.24970698 |
| 87 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.24646543 |
| 88 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.23416384 |
| 89 | positive regulation of mast cell degranulation (GO:0043306) | 3.23416384 |
| 90 | neutrophil mediated immunity (GO:0002446) | 3.23164082 |
| 91 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.22360550 |
| 92 | exploration behavior (GO:0035640) | 3.21244927 |
| 93 | response to interleukin-15 (GO:0070672) | 3.21240006 |
| 94 | synaptic transmission, dopaminergic (GO:0001963) | 3.19652145 |
| 95 | adaptation of signaling pathway (GO:0023058) | 3.18743052 |
| 96 | macrophage activation (GO:0042116) | 3.18683360 |
| 97 | fucose catabolic process (GO:0019317) | 3.18644473 |
| 98 | L-fucose metabolic process (GO:0042354) | 3.18644473 |
| 99 | L-fucose catabolic process (GO:0042355) | 3.18644473 |
| 100 | neurotransmitter secretion (GO:0007269) | 3.16082802 |
| 101 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.15817918 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 3.14378256 |
| 103 | behavioral response to cocaine (GO:0048148) | 3.13929424 |
| 104 | respiratory burst (GO:0045730) | 3.10886665 |
| 105 | granulocyte activation (GO:0036230) | 3.09401751 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 3.09219215 |
| 107 | regulation of synaptic plasticity (GO:0048167) | 3.09052138 |
| 108 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.06542675 |
| 109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06416500 |
| 110 | regulation of glutamate secretion (GO:0014048) | 3.04977561 |
| 111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04962404 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.03936138 |
| 113 | detection of external biotic stimulus (GO:0098581) | 3.03610935 |
| 114 | synapse assembly (GO:0007416) | 3.03520657 |
| 115 | striatum development (GO:0021756) | 3.02836628 |
| 116 | behavioral defense response (GO:0002209) | 3.02075592 |
| 117 | behavioral fear response (GO:0001662) | 3.02075592 |
| 118 | regulation of neurotransmitter secretion (GO:0046928) | 3.01937145 |
| 119 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01078818 |
| 120 | membrane depolarization (GO:0051899) | 3.01049564 |
| 121 | gamma-aminobutyric acid transport (GO:0015812) | 2.99696361 |
| 122 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.99206900 |
| 123 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.99206900 |
| 124 | regulation of dendritic spine development (GO:0060998) | 2.98973577 |
| 125 | prepulse inhibition (GO:0060134) | 2.98715165 |
| 126 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98256359 |
| 127 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.96877726 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96789041 |
| 129 | response to host immune response (GO:0052572) | 2.96789041 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 2.95554000 |
| 131 | neurotransmitter transport (GO:0006836) | 2.93629218 |
| 132 | righting reflex (GO:0060013) | 2.93213907 |
| 133 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.91953678 |
| 134 | leukocyte degranulation (GO:0043299) | 2.90125322 |
| 135 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.89039346 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89030523 |
| 137 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88999385 |
| 138 | regulation of mast cell degranulation (GO:0043304) | 2.87847904 |
| 139 | learning (GO:0007612) | 2.87771213 |
| 140 | mast cell activation (GO:0045576) | 2.87757721 |
| 141 | positive regulation of dendritic spine development (GO:0060999) | 2.87589480 |
| 142 | DNA deamination (GO:0045006) | 2.86944157 |
| 143 | regulation of vesicle fusion (GO:0031338) | 2.86574815 |
| 144 | positive regulation of synapse maturation (GO:0090129) | 2.86338321 |
| 145 | response to amphetamine (GO:0001975) | 2.86324398 |
| 146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86140170 |
| 147 | fear response (GO:0042596) | 2.85920288 |
| 148 | interferon-gamma production (GO:0032609) | 2.85846316 |
| 149 | synaptic vesicle endocytosis (GO:0048488) | 2.85747083 |
| 150 | mechanosensory behavior (GO:0007638) | 2.85691755 |
| 151 | regulation of neurotransmitter transport (GO:0051588) | 2.84859910 |
| 152 | myeloid leukocyte mediated immunity (GO:0002444) | 2.84830962 |
| 153 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84661151 |
| 154 | detection of biotic stimulus (GO:0009595) | 2.84347546 |
| 155 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83828683 |
| 156 | proline transport (GO:0015824) | 2.83244530 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.83198372 |
| 158 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.83197367 |
| 159 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82151349 |
| 160 | B cell receptor signaling pathway (GO:0050853) | 2.80829144 |
| 161 | behavioral response to nicotine (GO:0035095) | 2.79058327 |
| 162 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.77930276 |
| 163 | cytidine deamination (GO:0009972) | 2.77685523 |
| 164 | cytidine metabolic process (GO:0046087) | 2.77685523 |
| 165 | cytidine catabolic process (GO:0006216) | 2.77685523 |
| 166 | regulation of synapse maturation (GO:0090128) | 2.77376647 |
| 167 | negative T cell selection (GO:0043383) | 2.76100495 |
| 168 | layer formation in cerebral cortex (GO:0021819) | 2.75295330 |
| 169 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.74005122 |
| 170 | L-amino acid import (GO:0043092) | 2.73391540 |
| 171 | positive regulation of synaptic transmission (GO:0050806) | 2.73206162 |
| 172 | female mating behavior (GO:0060180) | 2.72168458 |
| 173 | innervation (GO:0060384) | 2.71380901 |
| 174 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.70929022 |
| 175 | synaptic transmission (GO:0007268) | 2.70902834 |
| 176 | negative thymic T cell selection (GO:0045060) | 2.70307262 |
| 177 | regulation of female receptivity (GO:0045924) | 2.69662941 |
| 178 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.69367160 |
| 179 | dendrite development (GO:0016358) | 2.67362803 |
| 180 | neuronal ion channel clustering (GO:0045161) | 2.66915880 |
| 181 | regulation of B cell differentiation (GO:0045577) | 2.65222261 |
| 182 | positive thymic T cell selection (GO:0045059) | 2.63504016 |
| 183 | positive T cell selection (GO:0043368) | 2.62416570 |
| 184 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.61964818 |
| 185 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61189263 |
| 186 | negative regulation of interleukin-6 production (GO:0032715) | 2.59775765 |
| 187 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.57400020 |
| 188 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.57379227 |
| 189 | negative regulation of adaptive immune response (GO:0002820) | 2.56996873 |
| 190 | regulation of regulatory T cell differentiation (GO:0045589) | 2.55265649 |
| 191 | regulation of memory T cell differentiation (GO:0043380) | 2.54306637 |
| 192 | superoxide anion generation (GO:0042554) | 2.53381140 |
| 193 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.53242615 |
| 194 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.52293404 |
| 195 | dendritic cell migration (GO:0036336) | 2.50255500 |
| 196 | positive regulation of antigen processing and presentation (GO:0002579) | 2.49895822 |
| 197 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.47856269 |
| 198 | response to host (GO:0075136) | 2.47856269 |
| 199 | response to host defenses (GO:0052200) | 2.47856269 |
| 200 | defense response to protozoan (GO:0042832) | 2.47236980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.10787355 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.11147504 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02554330 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14423354 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96911514 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93356359 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88797299 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.88306580 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55434084 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55179625 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53508038 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51657593 |
| 13 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51657593 |
| 14 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50404436 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44120350 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.44057603 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26747719 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23458986 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.22543781 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.20014865 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19149950 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13934536 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13558823 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13198159 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11926396 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07769386 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.05271383 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03807609 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.03400592 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96137011 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93376584 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88488748 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88039553 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87714011 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86908934 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86791844 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83598436 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81837374 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80483728 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74055955 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.73099750 |
| 42 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70872822 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70579126 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.69448227 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68893505 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68665530 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68574618 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67154485 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55660928 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53892649 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53781716 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53172447 |
| 53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.51717351 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50496028 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50154712 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49898017 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.49052156 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47046275 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46376956 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45213766 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44415979 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44075010 |
| 63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41400696 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40239524 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39968886 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39338141 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35139322 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34767064 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33718419 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.33140750 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32777837 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31004902 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30635153 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29109684 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28120221 |
| 76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27701065 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26800537 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26706195 |
| 79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26589486 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26238276 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24922222 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.24478695 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23897282 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23612259 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23188384 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23123155 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22889791 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22710564 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22511276 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22095522 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21918240 |
| 92 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20162702 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19554617 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19549103 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19317085 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18849317 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17479735 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17395432 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16193373 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16150783 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.16038861 |
| 102 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15582888 |
| 103 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15199681 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13443187 |
| 105 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.13128364 |
| 106 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12671425 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11359507 |
| 108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11281432 |
| 109 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11059729 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10681556 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10681556 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10672825 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10451817 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10305799 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10211873 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09776605 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09230501 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09113678 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08374018 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08201597 |
| 121 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08125046 |
| 122 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07814271 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07752014 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06787179 |
| 125 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06219077 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05850260 |
| 127 | AR_19668381_ChIP-Seq_PC3_Human | 1.05301056 |
| 128 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03152978 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01926756 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00853418 |
| 131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00853418 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00540668 |
| 133 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00426044 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00260705 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00040106 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99839751 |
| 137 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99673684 |
| 138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99640463 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99392873 |
| 140 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99060081 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98198009 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97980531 |
| 143 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97845534 |
| 144 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97136719 |
| 145 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96772178 |
| 146 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96772178 |
| 147 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96352432 |
| 148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95280660 |
| 149 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94937114 |
| 150 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94058506 |
| 151 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93874280 |
| 152 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93469822 |
| 153 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89584067 |
| 154 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89296155 |
| 155 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88791891 |
| 156 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88733047 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88558687 |
| 158 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88526846 |
| 159 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88116470 |
| 160 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88028770 |
| 161 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87887049 |
| 162 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87887049 |
| 163 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87002922 |
| 164 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86323538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.93271756 |
| 2 | MP0003880_abnormal_central_pattern | 4.89738328 |
| 3 | MP0003724_increased_susceptibility_to | 4.01050291 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.54001067 |
| 5 | MP0002822_catalepsy | 3.50350976 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.44273457 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.40051522 |
| 8 | MP0009745_abnormal_behavioral_response | 3.16340187 |
| 9 | MP0004270_analgesia | 2.96372686 |
| 10 | MP0005671_abnormal_response_to | 2.92678946 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.92662692 |
| 12 | MP0009046_muscle_twitch | 2.80833798 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.80430968 |
| 14 | MP0001486_abnormal_startle_reflex | 2.80167306 |
| 15 | MP0002064_seizures | 2.78624390 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.63332084 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.58302932 |
| 18 | MP0001984_abnormal_olfaction | 2.51337793 |
| 19 | MP0001800_abnormal_humoral_immune | 2.49807136 |
| 20 | MP0003436_decreased_susceptibility_to | 2.48312160 |
| 21 | MP0002272_abnormal_nervous_system | 2.42805143 |
| 22 | MP0001986_abnormal_taste_sensitivity | 2.39069720 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 2.35425761 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.33240547 |
| 25 | MP0002419_abnormal_innate_immunity | 2.30206368 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.30007971 |
| 27 | MP0009785_altered_susceptibility_to | 2.21357044 |
| 28 | MP0000685_abnormal_immune_system | 2.19836087 |
| 29 | MP0005646_abnormal_pituitary_gland | 2.15582801 |
| 30 | MP0001790_abnormal_immune_system | 2.14764135 |
| 31 | MP0005387_immune_system_phenotype | 2.14764135 |
| 32 | MP0001188_hyperpigmentation | 2.14178017 |
| 33 | MP0002736_abnormal_nociception_after | 2.13785134 |
| 34 | MP0001440_abnormal_grooming_behavior | 2.13204704 |
| 35 | MP0002723_abnormal_immune_serum | 2.12139175 |
| 36 | MP0002735_abnormal_chemical_nociception | 2.11148109 |
| 37 | MP0005025_abnormal_response_to | 2.10617289 |
| 38 | MP0005000_abnormal_immune_tolerance | 2.09757196 |
| 39 | MP0006082_CNS_inflammation | 2.07061410 |
| 40 | MP0002254_reproductive_system_inflammat | 2.02257269 |
| 41 | MP0002452_abnormal_antigen_presenting | 2.00975038 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.98683951 |
| 43 | MP0001819_abnormal_immune_cell | 1.96610538 |
| 44 | MP0003303_peritoneal_inflammation | 1.91927580 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.88250052 |
| 46 | MP0003879_abnormal_hair_cell | 1.84457145 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.82338225 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.77453221 |
| 49 | MP0000778_abnormal_nervous_system | 1.72936784 |
| 50 | MP0001529_abnormal_vocalization | 1.72492179 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.71772735 |
| 52 | MP0003195_calcinosis | 1.70005956 |
| 53 | MP0009764_decreased_sensitivity_to | 1.68206625 |
| 54 | MP0002184_abnormal_innervation | 1.64822644 |
| 55 | MP0001970_abnormal_pain_threshold | 1.64731846 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.63109737 |
| 57 | MP0005409_darkened_coat_color | 1.62768558 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.62632290 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.61110842 |
| 60 | MP0001346_abnormal_lacrimal_gland | 1.59894327 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.57664526 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.56416895 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.55854021 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.52904959 |
| 65 | MP0008569_lethality_at_weaning | 1.52641770 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.49648924 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.49035015 |
| 68 | MP0004924_abnormal_behavior | 1.49035015 |
| 69 | MP0005253_abnormal_eye_physiology | 1.41922700 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.39823705 |
| 71 | MP0000716_abnormal_immune_system | 1.39025171 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.38098887 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.35633954 |
| 74 | MP0004742_abnormal_vestibular_system | 1.34516001 |
| 75 | MP0002909_abnormal_adrenal_gland | 1.33915433 |
| 76 | MP0004381_abnormal_hair_follicle | 1.31752277 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.31214013 |
| 78 | MP0002405_respiratory_system_inflammati | 1.30747024 |
| 79 | MP0003646_muscle_fatigue | 1.30697221 |
| 80 | MP0003787_abnormal_imprinting | 1.28164530 |
| 81 | MP0003866_abnormal_defecation | 1.27638044 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.27634904 |
| 83 | MP0001905_abnormal_dopamine_level | 1.27477078 |
| 84 | MP0002398_abnormal_bone_marrow | 1.26367233 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.26144323 |
| 86 | MP0003763_abnormal_thymus_physiology | 1.25510714 |
| 87 | MP0003136_yellow_coat_color | 1.23684545 |
| 88 | MP0001533_abnormal_skeleton_physiology | 1.23449464 |
| 89 | MP0004885_abnormal_endolymph | 1.22211338 |
| 90 | MP0006292_abnormal_olfactory_placode | 1.20637695 |
| 91 | MP0005464_abnormal_platelet_physiology | 1.19657601 |
| 92 | MP0002090_abnormal_vision | 1.19299836 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.18245097 |
| 94 | MP0002102_abnormal_ear_morphology | 1.17101816 |
| 95 | MP0000689_abnormal_spleen_morphology | 1.16448776 |
| 96 | MP0004130_abnormal_muscle_cell | 1.15946096 |
| 97 | MP0002928_abnormal_bile_duct | 1.15543097 |
| 98 | MP0002653_abnormal_ependyma_morphology | 1.12796499 |
| 99 | MP0004142_abnormal_muscle_tone | 1.12258120 |
| 100 | MP0001485_abnormal_pinna_reflex | 1.11756351 |
| 101 | MP0002752_abnormal_somatic_nervous | 1.11447040 |
| 102 | MP0003329_amyloid_beta_deposits | 1.10807312 |
| 103 | MP0004811_abnormal_neuron_physiology | 1.10264119 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 1.09515824 |
| 105 | MP0000955_abnormal_spinal_cord | 1.09126118 |
| 106 | MP0002638_abnormal_pupillary_reflex | 1.09099235 |
| 107 | MP0003183_abnormal_peptide_metabolism | 1.08866196 |
| 108 | MP0001963_abnormal_hearing_physiology | 1.08074976 |
| 109 | MP0004858_abnormal_nervous_system | 1.06257113 |
| 110 | MP0002229_neurodegeneration | 1.05917512 |
| 111 | MP0003045_fibrosis | 1.03385080 |
| 112 | MP0002722_abnormal_immune_system | 1.02707020 |
| 113 | MP0008469_abnormal_protein_level | 1.02324618 |
| 114 | MP0005394_taste/olfaction_phenotype | 1.02245486 |
| 115 | MP0005499_abnormal_olfactory_system | 1.02245486 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 1.00938768 |
| 117 | MP0000631_abnormal_neuroendocrine_gland | 1.00139617 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.97679876 |
| 119 | MP0000026_abnormal_inner_ear | 0.96733035 |
| 120 | MP0010386_abnormal_urinary_bladder | 0.96268352 |
| 121 | MP0003633_abnormal_nervous_system | 0.95516600 |
| 122 | MP0002429_abnormal_blood_cell | 0.94959599 |
| 123 | MP0001177_atelectasis | 0.92620121 |
| 124 | MP0008872_abnormal_physiological_respon | 0.92449658 |
| 125 | MP0002152_abnormal_brain_morphology | 0.92301583 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.91490055 |
| 127 | MP0004883_abnormal_blood_vessel | 0.90030231 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.89835530 |
| 129 | MP0000427_abnormal_hair_cycle | 0.87190694 |
| 130 | MP0005377_hearing/vestibular/ear_phenot | 0.87133274 |
| 131 | MP0003878_abnormal_ear_physiology | 0.87133274 |
| 132 | MP0005195_abnormal_posterior_eye | 0.85859731 |
| 133 | MP0002132_abnormal_respiratory_system | 0.83865213 |
| 134 | MP0003690_abnormal_glial_cell | 0.83604709 |
| 135 | MP0003828_pulmonary_edema | 0.82687436 |
| 136 | MP0009278_abnormal_bone_marrow | 0.81765758 |
| 137 | MP0002095_abnormal_skin_pigmentation | 0.81626497 |
| 138 | MP0000703_abnormal_thymus_morphology | 0.80649508 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.80356602 |
| 140 | MP0005171_absent_coat_pigmentation | 0.79669466 |
| 141 | MP0003631_nervous_system_phenotype | 0.79413688 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.79256991 |
| 143 | MP0008004_abnormal_stomach_pH | 0.79177732 |
| 144 | MP0008874_decreased_physiological_sensi | 0.77353208 |
| 145 | MP0001663_abnormal_digestive_system | 0.76924608 |
| 146 | MP0001664_abnormal_digestion | 0.75938829 |
| 147 | MP0004085_abnormal_heartbeat | 0.72632756 |
| 148 | MP0000465_gastrointestinal_hemorrhage | 0.71628568 |
| 149 | MP0004145_abnormal_muscle_electrophysio | 0.71427438 |
| 150 | MP0003938_abnormal_ear_development | 0.71072152 |
| 151 | MP0003634_abnormal_glial_cell | 0.70038877 |
| 152 | MP0003011_delayed_dark_adaptation | 0.69882432 |
| 153 | MP0005310_abnormal_salivary_gland | 0.69859112 |
| 154 | MP0004215_abnormal_myocardial_fiber | 0.69412422 |
| 155 | MP0000920_abnormal_myelination | 0.64480064 |
| 156 | MP0003075_altered_response_to | 0.64437821 |
| 157 | MP0008789_abnormal_olfactory_epithelium | 0.61153734 |
| 158 | MP0001348_abnormal_lacrimal_gland | 0.58158427 |
| 159 | MP0005535_abnormal_body_temperature | 0.57974685 |
| 160 | MP0001943_abnormal_respiration | 0.56799749 |
| 161 | MP0004484_altered_response_of | 0.56441966 |
| 162 | MP0003137_abnormal_impulse_conducting | 0.54275445 |
| 163 | MP0000566_synostosis | 0.52234623 |
| 164 | MP0002249_abnormal_larynx_morphology | 0.51105594 |
| 165 | MP0004510_myositis | 0.49932729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.15906071 |
| 2 | Stomatitis (HP:0010280) | 4.92436110 |
| 3 | Myokymia (HP:0002411) | 4.81431789 |
| 4 | Focal seizures (HP:0007359) | 4.70816160 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.70503391 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.65088694 |
| 7 | Optic neuritis (HP:0100653) | 4.65088694 |
| 8 | Congenital stationary night blindness (HP:0007642) | 4.65060612 |
| 9 | Myositis (HP:0100614) | 4.61974818 |
| 10 | Febrile seizures (HP:0002373) | 4.48645257 |
| 11 | Orchitis (HP:0100796) | 4.37755746 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37080872 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.32903021 |
| 14 | Recurrent abscess formation (HP:0002722) | 4.25718533 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 3.91138224 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.91138224 |
| 17 | Abnormal ciliary motility (HP:0012262) | 3.80999795 |
| 18 | Atonic seizures (HP:0010819) | 3.76285908 |
| 19 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.67188088 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.62241962 |
| 21 | Absence seizures (HP:0002121) | 3.59886671 |
| 22 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.58417245 |
| 23 | Hyperventilation (HP:0002883) | 3.53019113 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52867555 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.48740245 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.38712371 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.38045612 |
| 28 | Amblyopia (HP:0000646) | 3.33753194 |
| 29 | Generalized tonic-clonic seizures (HP:0002069) | 3.33191034 |
| 30 | Dialeptic seizures (HP:0011146) | 3.32874562 |
| 31 | Broad-based gait (HP:0002136) | 3.32145959 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.31941572 |
| 33 | Visual hallucinations (HP:0002367) | 3.24655036 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.22901439 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21909409 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21909409 |
| 37 | Stomach cancer (HP:0012126) | 3.16832757 |
| 38 | Abnormality of macular pigmentation (HP:0008002) | 3.16568081 |
| 39 | Encephalitis (HP:0002383) | 3.13584840 |
| 40 | Recurrent skin infections (HP:0001581) | 3.10427695 |
| 41 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.10150289 |
| 42 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.10150289 |
| 43 | Keratoconjunctivitis (HP:0001096) | 3.09375557 |
| 44 | Nuclear cataract (HP:0100018) | 3.07874600 |
| 45 | Dyschromatopsia (HP:0007641) | 3.04828094 |
| 46 | Keratoconjunctivitis sicca (HP:0001097) | 3.02787103 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 3.00687547 |
| 48 | Hemiplegia (HP:0002301) | 2.97991545 |
| 49 | Decreased central vision (HP:0007663) | 2.90297650 |
| 50 | Hemoptysis (HP:0002105) | 2.86352430 |
| 51 | Pancreatic cysts (HP:0001737) | 2.83540226 |
| 52 | Meningitis (HP:0001287) | 2.83013126 |
| 53 | Gaze-evoked nystagmus (HP:0000640) | 2.78467156 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.76130319 |
| 55 | Vasculitis (HP:0002633) | 2.72901499 |
| 56 | Hypochromic anemia (HP:0001931) | 2.71331044 |
| 57 | Leukocytosis (HP:0001974) | 2.70733743 |
| 58 | Chronic otitis media (HP:0000389) | 2.70178864 |
| 59 | Episodic fever (HP:0001954) | 2.66043392 |
| 60 | Gait imbalance (HP:0002141) | 2.65710078 |
| 61 | Congenital primary aphakia (HP:0007707) | 2.65415300 |
| 62 | Zonular cataract (HP:0010920) | 2.61914254 |
| 63 | T lymphocytopenia (HP:0005403) | 2.57087602 |
| 64 | Obstructive lung disease (HP:0006536) | 2.56426794 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56426794 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.56420305 |
| 67 | Dysdiadochokinesis (HP:0002075) | 2.55397988 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.54881176 |
| 69 | Supranuclear gaze palsy (HP:0000605) | 2.53194299 |
| 70 | Drooling (HP:0002307) | 2.49204729 |
| 71 | Excessive salivation (HP:0003781) | 2.49204729 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.49175534 |
| 73 | Abolished electroretinogram (ERG) (HP:0000550) | 2.48689658 |
| 74 | Hemiparesis (HP:0001269) | 2.47322504 |
| 75 | Poor eye contact (HP:0000817) | 2.45953965 |
| 76 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.45055976 |
| 77 | Medial flaring of the eyebrow (HP:0010747) | 2.44933033 |
| 78 | Central scotoma (HP:0000603) | 2.43399594 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 2.42271882 |
| 80 | Rhinitis (HP:0012384) | 2.41643826 |
| 81 | * Amelogenesis imperfecta (HP:0000705) | 2.41341288 |
| 82 | Aplasia involving bones of the extremities (HP:0009825) | 2.40924221 |
| 83 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.40924221 |
| 84 | Aplasia of the phalanges of the hand (HP:0009802) | 2.40924221 |
| 85 | Action tremor (HP:0002345) | 2.39490923 |
| 86 | Dysmetria (HP:0001310) | 2.38977018 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.36866260 |
| 88 | Abnormality of T cells (HP:0002843) | 2.33947861 |
| 89 | Anxiety (HP:0000739) | 2.29867621 |
| 90 | Absent speech (HP:0001344) | 2.29133727 |
| 91 | Chest pain (HP:0100749) | 2.28179875 |
| 92 | Abnormality of midbrain morphology (HP:0002418) | 2.27176281 |
| 93 | Molar tooth sign on MRI (HP:0002419) | 2.27176281 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 2.24029472 |
| 95 | Abnormality of binocular vision (HP:0011514) | 2.23373427 |
| 96 | Diplopia (HP:0000651) | 2.23373427 |
| 97 | Urticaria (HP:0001025) | 2.20424216 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19084873 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.17505425 |
| 100 | Truncal ataxia (HP:0002078) | 2.17287109 |
| 101 | Anorexia (HP:0002039) | 2.16686812 |
| 102 | Genital tract atresia (HP:0001827) | 2.15946152 |
| 103 | Abnormal social behavior (HP:0012433) | 2.15004132 |
| 104 | Impaired social interactions (HP:0000735) | 2.15004132 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.14944712 |
| 106 | Pulmonary embolism (HP:0002204) | 2.14451146 |
| 107 | Genetic anticipation (HP:0003743) | 2.13446145 |
| 108 | Arterial thrombosis (HP:0004420) | 2.13424760 |
| 109 | Progressive inability to walk (HP:0002505) | 2.13156760 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12115520 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 2.11411554 |
| 112 | Type II lissencephaly (HP:0007260) | 2.11224967 |
| 113 | Eosinophilia (HP:0001880) | 2.10030385 |
| 114 | Epileptiform EEG discharges (HP:0011182) | 2.09150711 |
| 115 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09124942 |
| 116 | Vaginal atresia (HP:0000148) | 2.08971736 |
| 117 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.08934576 |
| 118 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.08003251 |
| 119 | Onycholysis (HP:0001806) | 2.05836818 |
| 120 | Abnormality of eosinophils (HP:0001879) | 2.05081052 |
| 121 | Abnormality of salivation (HP:0100755) | 2.04962751 |
| 122 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04856802 |
| 123 | Pustule (HP:0200039) | 2.04758167 |
| 124 | Polydipsia (HP:0001959) | 2.03616491 |
| 125 | Abnormal drinking behavior (HP:0030082) | 2.03616491 |
| 126 | Nephronophthisis (HP:0000090) | 2.03493757 |
| 127 | Spontaneous hematomas (HP:0007420) | 2.02562528 |
| 128 | Inability to walk (HP:0002540) | 2.01759130 |
| 129 | Thickened helices (HP:0000391) | 2.01476275 |
| 130 | Gangrene (HP:0100758) | 2.01069027 |
| 131 | Vertigo (HP:0002321) | 2.00623080 |
| 132 | Prolonged QT interval (HP:0001657) | 1.99122637 |
| 133 | Megalencephaly (HP:0001355) | 1.99081275 |
| 134 | Agitation (HP:0000713) | 1.97748128 |
| 135 | Scanning speech (HP:0002168) | 1.97154658 |
| 136 | Stereotypic behavior (HP:0000733) | 1.95494657 |
| 137 | Ankle clonus (HP:0011448) | 1.94749100 |
| 138 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.94306442 |
| 139 | Constricted visual fields (HP:0001133) | 1.94225217 |
| 140 | Abnormality of the pleura (HP:0002103) | 1.93795996 |
| 141 | Abnormality of T cell physiology (HP:0011840) | 1.93608081 |
| 142 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93204543 |
| 143 | Postural instability (HP:0002172) | 1.92162967 |
| 144 | Depression (HP:0000716) | 1.91985662 |
| 145 | Recurrent bronchitis (HP:0002837) | 1.91737757 |
| 146 | Amyloidosis (HP:0011034) | 1.91124070 |
| 147 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89801712 |
| 148 | Abnormality of the renal cortex (HP:0011035) | 1.89129604 |
| 149 | Scotoma (HP:0000575) | 1.88909150 |
| 150 | Septo-optic dysplasia (HP:0100842) | 1.85713061 |
| 151 | Severe visual impairment (HP:0001141) | 1.85047409 |
| 152 | Lower limb amyotrophy (HP:0007210) | 1.83306605 |
| 153 | Widely spaced teeth (HP:0000687) | 1.82361011 |
| 154 | Hypothermia (HP:0002045) | 1.82260199 |
| 155 | Gingival bleeding (HP:0000225) | 1.82023260 |
| 156 | Tubulointerstitial nephritis (HP:0001970) | 1.81572163 |
| 157 | Blue irides (HP:0000635) | 1.81369460 |
| 158 | Abnormality of the renal medulla (HP:0100957) | 1.81237326 |
| 159 | Chronic sinusitis (HP:0011109) | 1.80459331 |
| 160 | Gingivitis (HP:0000230) | 1.80159968 |
| 161 | Granulocytopenia (HP:0001913) | 1.80074444 |
| 162 | IgG deficiency (HP:0004315) | 1.79960248 |
| 163 | Clumsiness (HP:0002312) | 1.76892392 |
| 164 | Status epilepticus (HP:0002133) | 1.76724235 |
| 165 | Abnormal eating behavior (HP:0100738) | 1.76301002 |
| 166 | Impaired smooth pursuit (HP:0007772) | 1.76192208 |
| 167 | Alveolar cell carcinoma (HP:0006519) | 1.75470745 |
| 168 | Macular degeneration (HP:0000608) | 1.75161963 |
| 169 | Retinal dysplasia (HP:0007973) | 1.75064408 |
| 170 | Exotropia (HP:0000577) | 1.74597304 |
| 171 | Abnormal EKG (HP:0003115) | 1.74404500 |
| 172 | True hermaphroditism (HP:0010459) | 1.73626563 |
| 173 | Pancreatic fibrosis (HP:0100732) | 1.72349919 |
| 174 | Specific learning disability (HP:0001328) | 1.71012159 |
| 175 | Spastic gait (HP:0002064) | 1.69370722 |
| 176 | Poor coordination (HP:0002370) | 1.68154039 |
| 177 | Lower limb muscle weakness (HP:0007340) | 1.67879129 |
| 178 | Corneal dystrophy (HP:0001131) | 1.67543144 |
| 179 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.67405619 |
| 180 | Torticollis (HP:0000473) | 1.66785558 |
| 181 | Protruding tongue (HP:0010808) | 1.66452531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.95025576 |
| 2 | NTRK3 | 4.26062592 |
| 3 | FRK | 3.95558121 |
| 4 | CASK | 3.66687786 |
| 5 | TAOK3 | 2.86983861 |
| 6 | MAP4K1 | 2.78501192 |
| 7 | TXK | 2.76341353 |
| 8 | MAP3K4 | 2.67942869 |
| 9 | TNIK | 2.62091747 |
| 10 | MAP2K7 | 2.47577407 |
| 11 | MARK1 | 2.35703551 |
| 12 | DAPK2 | 2.21156384 |
| 13 | NTRK2 | 2.19539523 |
| 14 | MAP3K9 | 2.03022821 |
| 15 | RIPK4 | 2.02993609 |
| 16 | IRAK4 | 1.97413567 |
| 17 | PNCK | 1.87411771 |
| 18 | GRK6 | 1.85045664 |
| 19 | SYK | 1.80581779 |
| 20 | CSK | 1.78671556 |
| 21 | TLK1 | 1.74654975 |
| 22 | BMPR1B | 1.72524653 |
| 23 | FES | 1.66229656 |
| 24 | TYK2 | 1.63796538 |
| 25 | ACVR1B | 1.62623775 |
| 26 | PAK6 | 1.59680261 |
| 27 | MINK1 | 1.57058010 |
| 28 | PINK1 | 1.45146866 |
| 29 | BTK | 1.42666694 |
| 30 | ZAK | 1.38915110 |
| 31 | ZAP70 | 1.38767077 |
| 32 | SIK2 | 1.38481980 |
| 33 | MAP3K13 | 1.38217279 |
| 34 | MAP2K3 | 1.35325658 |
| 35 | CDK5 | 1.34323102 |
| 36 | MAPK13 | 1.33850855 |
| 37 | PLK2 | 1.31606308 |
| 38 | GRK1 | 1.30870936 |
| 39 | IKBKE | 1.28399620 |
| 40 | TEC | 1.26813630 |
| 41 | KIT | 1.26465102 |
| 42 | HCK | 1.26056630 |
| 43 | GRK5 | 1.25788748 |
| 44 | BMPR2 | 1.23148056 |
| 45 | CAMK2A | 1.21318224 |
| 46 | LYN | 1.20599975 |
| 47 | MAP2K4 | 1.19851548 |
| 48 | NTRK1 | 1.19552571 |
| 49 | ITK | 1.18182006 |
| 50 | NME1 | 1.15329868 |
| 51 | PRKCG | 1.13807727 |
| 52 | CAMK2B | 1.11231398 |
| 53 | MAP3K12 | 1.09930080 |
| 54 | PRPF4B | 1.08357261 |
| 55 | JAK3 | 1.07408355 |
| 56 | IKBKB | 1.06437429 |
| 57 | DAPK1 | 1.05535880 |
| 58 | NEK6 | 1.04999645 |
| 59 | JAK2 | 1.03336736 |
| 60 | MAP4K2 | 1.02632230 |
| 61 | LCK | 1.02343280 |
| 62 | MAP3K14 | 1.01755309 |
| 63 | IRAK1 | 1.01280010 |
| 64 | CDK3 | 0.97658083 |
| 65 | KSR1 | 0.97610371 |
| 66 | FGR | 0.97225294 |
| 67 | DYRK1A | 0.95414813 |
| 68 | CSF1R | 0.94320049 |
| 69 | SGK223 | 0.94303994 |
| 70 | SGK494 | 0.94303994 |
| 71 | CAMKK1 | 0.93263649 |
| 72 | PIK3CG | 0.93259435 |
| 73 | PTK2B | 0.93002636 |
| 74 | MAP3K11 | 0.89892646 |
| 75 | SGK1 | 0.89823298 |
| 76 | CAMK1 | 0.88804070 |
| 77 | PRKCE | 0.88499560 |
| 78 | JAK1 | 0.88129499 |
| 79 | SGK2 | 0.88055095 |
| 80 | KSR2 | 0.87931586 |
| 81 | AKT3 | 0.85030973 |
| 82 | MARK3 | 0.84838480 |
| 83 | PRKD3 | 0.84748073 |
| 84 | STK38 | 0.83175056 |
| 85 | OXSR1 | 0.82622037 |
| 86 | STK11 | 0.82615333 |
| 87 | INSRR | 0.81798957 |
| 88 | MARK2 | 0.81512804 |
| 89 | MAPK15 | 0.81353821 |
| 90 | PHKG2 | 0.78730510 |
| 91 | PHKG1 | 0.78730510 |
| 92 | TYRO3 | 0.78141046 |
| 93 | WNK3 | 0.77704343 |
| 94 | CAMK1G | 0.76515050 |
| 95 | PKN1 | 0.75045313 |
| 96 | PAK3 | 0.73350898 |
| 97 | CAMK2D | 0.72411010 |
| 98 | GRK7 | 0.69850570 |
| 99 | MAP2K6 | 0.68741787 |
| 100 | NUAK1 | 0.68365276 |
| 101 | FER | 0.66390462 |
| 102 | MUSK | 0.66147891 |
| 103 | MAP3K2 | 0.66145896 |
| 104 | WNK1 | 0.65267408 |
| 105 | ARAF | 0.64939970 |
| 106 | PRKCH | 0.64781313 |
| 107 | FGFR2 | 0.64635434 |
| 108 | CDC42BPA | 0.63983607 |
| 109 | UHMK1 | 0.63167542 |
| 110 | ADRBK2 | 0.62461377 |
| 111 | MAP3K1 | 0.60909662 |
| 112 | NLK | 0.59926267 |
| 113 | WNK4 | 0.57212893 |
| 114 | TAOK1 | 0.57055922 |
| 115 | TNK2 | 0.56796492 |
| 116 | CAMKK2 | 0.56387161 |
| 117 | BLK | 0.56256539 |
| 118 | CDK18 | 0.52795798 |
| 119 | PDPK1 | 0.52262453 |
| 120 | ADRBK1 | 0.52250058 |
| 121 | ROCK2 | 0.52148744 |
| 122 | MATK | 0.52027805 |
| 123 | STK39 | 0.51896622 |
| 124 | EPHA3 | 0.51755746 |
| 125 | CDK15 | 0.51659746 |
| 126 | CDK19 | 0.51559508 |
| 127 | CAMK2G | 0.50285158 |
| 128 | PRKCZ | 0.49906616 |
| 129 | FYN | 0.49705050 |
| 130 | SGK3 | 0.48906435 |
| 131 | YES1 | 0.48413457 |
| 132 | MAP3K3 | 0.48234109 |
| 133 | BCR | 0.48078929 |
| 134 | MAPK12 | 0.48047784 |
| 135 | MAP3K7 | 0.47285784 |
| 136 | CDK14 | 0.46623465 |
| 137 | PRKACA | 0.46340318 |
| 138 | PRKCB | 0.46161211 |
| 139 | TBK1 | 0.45839391 |
| 140 | PRKG1 | 0.45248998 |
| 141 | RAF1 | 0.45089617 |
| 142 | RPS6KA3 | 0.44677177 |
| 143 | CAMK4 | 0.43916201 |
| 144 | CDK11A | 0.43701213 |
| 145 | PRKCA | 0.42444047 |
| 146 | PDK1 | 0.41958096 |
| 147 | PRKCQ | 0.41687903 |
| 148 | IRAK2 | 0.41592585 |
| 149 | PIM1 | 0.41294470 |
| 150 | PRKAA2 | 0.41221619 |
| 151 | MAPK10 | 0.40160154 |
| 152 | PRKD2 | 0.40100141 |
| 153 | MAPK7 | 0.39422953 |
| 154 | DMPK | 0.38502752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.98207637 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.08590734 |
| 3 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.94514011 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.85949284 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.81272798 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76582547 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.75274649 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72434741 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61929275 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.48969294 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45708165 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.43772660 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.39081429 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38973762 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.34357029 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 2.32215095 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27241704 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20853686 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14673792 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10740415 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06028691 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 2.05596025 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.02481458 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94696927 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.92289816 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.88439919 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87511987 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84890999 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84860968 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.82880796 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.79250766 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.75833270 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74805433 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.64809643 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64455507 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61926158 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.58516174 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.57275635 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47917420 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43881022 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42721551 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42170861 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41006456 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37828187 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37776452 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35670143 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35358484 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35245371 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29496651 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29488294 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.27867212 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23264709 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23154758 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20621263 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.16980577 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16019156 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.09686230 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08928606 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08387940 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06607798 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06599300 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 1.05733217 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05684862 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 1.04868520 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02571386 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01778893 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01755454 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00869554 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.98856038 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95911112 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95701917 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95168774 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93568509 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93134390 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92599731 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90768706 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89813032 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.88814426 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.88680711 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87013498 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86955128 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85671875 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84783362 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84442190 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83988976 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81696200 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80535138 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80094528 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79076219 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78878979 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78784292 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76129714 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.76094065 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75958369 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74289250 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73939188 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.73481516 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71801694 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70849774 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.70752310 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69846655 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69439867 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68703167 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65918278 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65308550 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62119481 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61432636 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59847185 |
| 109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58078380 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57501957 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56904769 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56599116 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.55696698 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54669600 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53440234 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52669906 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52660957 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50844721 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50083402 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50083222 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48052405 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.46568354 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45023196 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.43200030 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.42013313 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39721576 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39520465 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39071340 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38672237 |
| 130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38219616 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35866348 |
| 132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34454161 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34404433 |
| 134 | Melanoma_Homo sapiens_hsa05218 | 0.33999155 |
| 135 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33390382 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28346941 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27148339 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26899950 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25500021 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23867680 |
| 141 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23547504 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.22160175 |
| 143 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21613800 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19263041 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.19022647 |
| 146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18169925 |
| 147 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17486489 |
| 148 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.17014721 |

